The Oncology Institute, Inc.
The Oncology Institute, Inc. (TOI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
toi · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for The Oncology Institute, Inc. (TOI) measures how much investors pay for each dollar of the company's trailing earnings. TOI's current PE ratio of N/A is calculated by dividing its stock price of $5.07 by its TTM earnings per share of -$0.04.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
The Oncology Institute, Inc.You TOI | $507M | N/A | — | -$0.04 |
 Agilon Health, Inc. AGL | $1.6B | N/A | — | -$24.48 |
 Auna S.A. AUNA | $335M | 5.10x | — | $3.24 |
 Autolus Therapeutics plc AUTL | $389M | N/A | — | -$1.08 |
 CeriBell, Inc. CBLL | $688M | N/A | — | -$1.46 |
 Cross Country Healthcare, Inc. CCRN | $426M | N/A | — | -$2.93 |
 Enhabit, Inc. EHAB | $707M | N/A | — | -$0.09 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.07 | — | |
2024-12-31 FY2024 | — | $-0.86 | — | |
2023-12-31 FY2023 | — | $-1.13 | — | |
2022-12-31 FY2022 | 790.19x | $0.00 | — | |
2021-12-31 FY2021 | — | $-0.16 | — | |
2020-12-31 FY2020 | — | $-0.24 | — | |
2019-12-31 FY2019 | — | $-0.06 | — | |
2018-12-31 FY2018 | 158.34x | $0.06 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for The Oncology Institute, Inc. (TOI) measures how much investors pay for each dollar of the company's trailing earnings. TOI's current PE ratio of N/A is calculated by dividing its stock price of $5.07 by its TTM earnings per share of -$0.04.
Frequently asked questions
TOI pe ratio · 6 questionsTOI's current PE ratio is N/A as of 2026-06-08, based on a stock price of $5.07 and TTM EPS of -$0.04. Data sourced from Financial Modeling Prep via TOI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · The Oncology Institute, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08